Company: APM
Filing Date: 2025-07-15
Form Type: DRS
Source: 0001213900-25-063899
Chunk: 314

Company: Aptorum Group Ltd
Filing Date: 2025-07-15
Form: DRS
Chunk 314
---
 goals and objectives;                                                                             |
| ● | evaluating the performance of our executive officers in light of the goals and objectives of our executive compensation plans and recommending to our Board of Directors with respect to the compensation of our executive officers;   |
| ● | reviewing the goals and objectives of our general compensation plans and other employee benefit plans as well as our general compensation plans and other employee benefit plans in light of such goals and objectives;                |
| ● | retaining and approving the compensation of any compensation advisors;                                                                                                                                                                 |
| ● | reviewing all equity-compensation plans to be submitted for shareholder approval under the NASDAQ listing rules, and reviewing and approving all equity-compensation plans that are exempt from such shareholder approval requirement; |
| ● | evaluating the appropriate level of compensation for board and board committee service by non-employee directors; and                                                                                                                  |
| ● | reviewing and approving description of executive compensation included in our Annual Report on Form 20-F.                                                                                                                              |

Nominating and Corporate Governance Committee

Douglas Arner (chair) and
Justin Wu currently serve on the nominating and corporate governance committee, which is chaired by Professor Arner. Our Board of Directors
has determined that each member of the nominating and corporate governance committee is “independent” as that term is defined
in the applicable rules of the Nasdaq Capital Market. The nominating and corporate governance committee’s responsibilities include:

| ● | assisting our Board of Directors in identifying prospective director nominees and recommending nominees for election by the shareholders or appointment by our Board of Directors;                                                                                                                                                          |
| ● | advising the board of directors periodically with respect to significant developments in the law and practice of corporate governance as well as our compliance with applicable laws and regulations, and making recommendations to our Board of Directors on all matters of corporate governance and on any corrective action to be taken; |
| ● | overseeing the evaluation of our Board of Directors; and                                                                                                                                                                                                                                                                                    |
| ● | recommending members for each board committee of our Board of Directors.                                                                                                                                                                                                                                                                    |

<div align='center'>168</div>

Scientific Advisory Board

We restructured the Scientific
Assessment Committee into a Scientific Advisory Board. The Scientific Advisory Board shall help the Company sharpen its focus on innovation
and technological advancements and address critical scientific challenges in our research and development; it will provide overall advise
on the scientific development of the company. As of the date of this prospectus, we have 29 members on this board.

In light of the Company’s
focus on developing treatment for infectious diseases, we